37 results about "Acute upper respiratory infection" patented technology

The present invention relates to an extract isolated from Sophorae Radix useful for prevention and treatment of respiratory diseases. More specifically, the present invention relates to a pharmaceutical drug comprising the Sophorae Radix extract having excellent effects of inhibiting airway contraction, respiratory infections, 5-lipoxygenase activity, phosphodiesterase 4 activity, airway hyper-responsiveness and airway remodeling; antagonistic activity against leukotriene D4; and an antitussive effect, thus being useful for prevention and treatment of respiratory diseases such as asthma, acute or chronic bronchitis, allergic rhinitis, acute upper respiratory infections and acute lower respiratory infections, and the like.

The invention discloses a traditional Chinese medicinal preparation for treating acute upper respiratory infection and a preparation method of the traditional Chinese medicinal preparation and belongs to the field of traditional Chinese medicines. The traditional Chinese medicinal preparation for treating the acute upper respiratory infection is prepared from extracts of honeysuckle, folium vilicis negundo, evodia lepta, wild chrysanthemum flower, south isatis root and holly root, acetaminophen, chlorpheniramine maleate, caffeine and beta cyclodextrin. The traditional Chinese medicinal preparation for treating the acute upper respiratory infection is based on basic pathogenesis of wind, warmness, heat and toxin, medicines with dispelling, relieving, eliminating and promoting effects are selected and combined for jointly realizing the effects of dispelling wind, relieving symptoms and clearing away heat and toxic materials, and the traditional Chinese medicinal preparation for treating the acute upper respiratory infection is sucrose-free granules and has the advantages of high stability, low dosage of auxiliary materials and wide application range. The preparation method of the traditional Chinese medicinal preparation for treating the acute upper respiratory infection has the advantage that active ingredients in each component of the traditional Chinese medicinal preparation are distinguished, processed and refined; and the preparation method of the traditional Chinese medicinal preparation for treating the acute upper respiratory infection is simple, has a broad market prospect and is applicable to large scale production.

The invention discloses a Chinese materia medica preparation for treating child acute upper respiratory infection, and belongs to the field of traditional Chinese medicines. The Chinese materia medica preparation for treating the child acute upper respiratory infection is made of the following bulk drugs, by part of weight, indigo naturalis 12, cocklebur fruit 10, platycodon grandiflorum 8, wild chrysanthemum flower 12, semen plantaginis 6, burdock 8, oroxylum indicum 6, honeysuckle 10, reed rhizome 10, the root of common peony 9, field mint 8, pericarpium citri reticulatae 9 and lilium brownie 6. According to the Chinese materia medica preparation for treating the child acute upper respiratory infection, natural traditional Chinese medicines are used as raw materials, curative effects are good, toxic and side effects do not exist, the child acute upper respiratory infection can be effectively cured, relapse cannot easily occur, and an effective rate reaches 98%.

The invention relates to a medicine for treating acute upper respiratory infection. The medicine for treating acute upper respiratory infection comprises the following components in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of dried ginger, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of angelica dahurica, 5-15 parts of inula flower, 10-30 parts of cowherb seed, 1-15 parts of herba aristolochiae, 10-20 parts of radix sileris, 15-30 parts of capillary artemisia, 20-30 parts of radix bupleuri, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of rhizoma imperatae, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of radix phytolaccae, 15-20 parts of butterflybush flower, 15-30 parts of glabrous sarcandra herb, 10-20 parts of radix ranunculi ternati, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of folium rhododendri daurici, 15-25 parts of rhizoma cyperi, 10-20 parts of calyx seu fructus physalis, 15-25 parts of white mulberry root-bark, 20-30 pars of lindley eupatorium, 1-20 parts of gorgon euryale seed and 10-25 parts of chinese azalea flower. All the components of the medicine for treating acute upper respiratory infection are natural materials, so that the medicine for treating the acute upper respiratory infection has good safety and clear curative effect and is suitable for large-scale application in clinic.

The invention relates to a preparation method and an application of a Magnolia flower volatile oil soft capsule for treating allergic rhinitis and associated diseases. The Magnolia flower volatile oil soft capsule contains the following ingredients in parts by volume: 1 to 90 parts of Magnolia flower volatile oil, 10 to 90 parts of oil phase, 0 to 50 parts of emulsifier and 0 to 30 of co-solvent. The Magnolia flower volatile oil soft capsule, provided by the invention, is also available in the form of an enteric-coated soft capsule, so as to reduce irritation to the stomach and enhance the patient compliance. The soft capsule provided by the invention is used for treating allergic rhinitis, acute rhinitis, simple rhinitis, hypertrophic rhinitis, atrophic rhinitis, acute nasosinusitis, chronic nasosinusitis or complications thereof, as well as respiratory diseases such as acute upper respiratory infection, acute / chronic obstructive lung disease and asthma, with remarkable curative effects.

The invention provides a Chinese medicinal composition for treating child acute upper respiratory tract infection. The Chinese medicinal composition consists of the following medicines in part by weight: 10 to 90 parts of patchouli, 30 to 130 parts of indigowoad leaf, 30 to 130 parts of fermented soybean, 30 to 130 parts of officinal magnolia bark, 30 to 130 parts of pachyrhizua angulatus, 10 to 90 parts of Chinese mosla herb, 100 to 220 parts of gypsum, 5 to 50 parts of coptis chinensis, 30 to 130 parts of scutellaria baicalensis, 10 to 110 parts of talcpowder, 5 to 50 parts of liquorice, 30 to 130 parts of honeysuckle, 10 to 90 parts of processed rhizoma pinelliae, and pharmaceutical excipients. The invention also provides a preparation method for the Chinese medicinal composition for treating child acute upper respiratory tract infection. The invention has the advantages that: the Chinese medicinal composition overcomes the defects of conventional formulations such as decoction and the like; by an alcohol extraction method, fat soluble active ingredients which have clinical effects in the composition are kept; and by efficient, and dynamic circulatory extraction equipment, the active ingredients are extracted to the maximum extent, and the clinical effects are guaranteed, and the Chinese medicinal composition has a solid clinical basis and good clinical effects.

The invention discloses a Chinese medicine preparation for treating acute upper respiratory infection. Chinese medicine science considers that upper respiratory infection is an acute nose, pharynx and throat inflammation caused by various pathogens. Chinese medicine slurry including the root of Chinese thorowax, heart leaves, Wilson barberry, thunberg fritillary bulb, ophiopogon latifolius, birthwort, citron, vietnamese sophora root, burdock, mint and balloon flower is prepared into decoction in a preparation room of the institute, and the Chinese medicine slurry has the functions of relieving the exterior syndrome with drugs pungent in flavor and cool in property, diminishing inflammation, removing toxicity, releasing lung qi, reducing phlegm, clearing heat and relieving cough and asthma. After clinical test, total effective rate is 96.0%, the temperature of a patient starts to drop after treatment, and the temperature recovery time of a treatment group is obviously shorter than that of a control group.

The invention discloses a Chinese medicinal preparation for treating heat clearing and detoxicating and its preparing process, wherein the preparation mainly comprises bear's gall 11.1g, wine-treated rhubarb 222.2g, black catechu 111.1g, borneol 22.2g, picrorhiza rhizome 166.7g, frankincense 33.4g and powder of natrii sulfas exsiccatus 22.2g. The preparation has good effect in treating acute upper respiratory tract infection.

The invention relates to an agent for treating acute upper respiratory infection. The agent is prepared from euphorbia kansui, liquorice, szechuan lovage rhizome, astragalus, dried ginger, fructus cnidii, divaricate saposhnikovia root, radix tinosporae, Indian iphigenia bulb, herba orostachyos, radix ophiopogonis, polygala tenuifolia, madder, the seed of cowherb and moutan bark. The agent for treating acute upper respiratory infection is reasonable in formula, simple and readily available in components and obvious in curative effect and does not have an obvious side effect.

The invention discloses a traditional Chinese medicine composition used for treating infantile acute upper respiratory infection, and a preparation method thereof. The traditional Chinese medicine composition is capable of reducing fever, resisting imflammation, and resisting bacteria obviously, and can be used for treating infantile acute upper respiratory infection. A medicine which is more excellent in curative effect and is more convenient to use, is prepared from the traditional Chinese medicine composition and pharmaceutically acceptable auxiliary materials, and is prepared into oral liquid, granulas, tablets, capsules, dripping pill, soft capsules, and oral effervecent tablets.

The invention discloses a traditional Chinese medicine for clearing away lung-heat and application of the traditional Chinese medicine to preparation of medicine for treating acute upper respiratory infection, the traditional Chinese medicine for clearing away lung-heat and abating fever is prepared from the following raw material medicines in parts by weight: 15-30 parts of wild buckwheat rhizome, 9-15 parts of fried scutellaria baicalensis, 4-9 parts of perilla leaf, 4-9 parts of mint, 4-9 parts of radix peucedani, 4-9 parts of bupleurum chinense, 15-30 parts of artemisia apiacea and 15-30 parts of folium isatidis. The traditional Chinese medicine composition is prepared from, by weight, 4-9 parts of rhizoma belamcandae, 4-12 parts of platycodon grandiflorum, 4-12 parts of cortex mori, 4-12 parts of thunberg fritillary bulb, 4-15 parts of radix angelicae and 9-15 parts of medicated leaven. The traditional Chinese medicine composition is used for treating acute upper respiratory infection, relieving of symptoms such as fever can be obviously accelerated, and disease healing is promoted; the medicine has the effects of clearing lung and abating fever, and is reliable in curative effect; the raw materials are easy to obtain, low in price, convenient to manufacture and wide in application range.

The invention relates to a traditional Chinese medicinal preparation for treating infantile pneumonia and a preparation method of the traditional Chinese medicinal preparation. The traditional Chinese medicinal preparation is prepared into a pharmaceutically acceptable preparation by decocting, filtering, condensing, mixing, sieving, drying and implementing other treatment on the following crude medicines in parts by weight: 175-250 parts of ephedra, 175-250 parts of scutellaria baicalensis, 175-250 parts of fructus perillae, 250-350 parts of liquorice, 250-350 parts of root bark of white mulberry, 250-370 parts of semen armeniacae amarae, 450-550 parts of cortex lycii radicis, 750-850 parts of gypsum and 200-270 parts of trichosanthes kirilowii maxim. The preparation is a pure traditional Chinese medicinal preparation, which is concrete in curative effect and low in toxic and side effect; the preparation, on treating common and frequently-occurring diseases in children such as acute upper respiratory infection, trachitis, pneumonia and the like, treats both symptoms and root causes, and can help patients rapidly recover. Meanwhile, the preparation, after being prepared into granules, facilitates patients to carry and take, and is good in taste, controllable in quality and good in safety.

The present invention relates to a composition for preventing or treating a respiratory disease containing an active ingredient in the form of a mixed herbal extract of Cnidii Rhizoma and Polygoni cuspidati Radix, and relates to a production method therefor. The mixed herbal extract of Cnidii Rhizoma and Polygoni cuspidati Radix has an outstanding 5-lipoxygenase suppressing activity, airway constriction suppressing activity, airway inflammation suppressing action, ear-swelling anti-inflammatory effect and antitussive and phlegm-loosening action, and has been confirmed to be useful in preventing or treating respiratory diseases including asthma, chronic obstructive pulmonary disease, acute and chronic bronchitis, allergic rhinitis, cough, expectoration, acute lower respiratory infections (bronchitis and bronchiolitis), and acute upper respiratory infections such an pharyngitis, tonsillitis and laryngitis.

The present invention relates to a composition for preventing or treating a respiratory disease containing an active ingredient in the form of a mixed herbal extract of Cnidium officinale root (Cnidii Rhizoma) and Polygoni cuspidati root (Polygoni cuspidati Radix), and relates to a production method therefor. The mixed herbal extract of Cnidium officinale root and Polygoni cuspidati root has an outstanding 5-lipoxygenase suppressing activity, airway constriction suppressing activity, airway inflammation suppressing action, ear-swelling anti-inflammatory effect and antitussive and phlegm- loosening action, and has been confirmed to be useful in preventing or treating respiratory diseases including asthma, chronic obstructive pulmonary disease, acute and chronic bronchitis, allergic rhinitis, cough, expectoration, acute lower respiratory infections (bronchitis and bronchiolitis), and acute upper respiratory infections such as pharyngitis, tonsillitis and laryngitis.

The invention relates to oral liquid for relieving Children children acute upper respiratory infection symptoms, and belongs to health care food. The oral liquid is prepared by adding cosolvents and purified water into extracts obtained from medical materials of herba houttuyniae, honeysuckle flowers and herba elsholtziaeelsholtzia through supercritical CO2 extraction via and performing ultrafiltration. The cosolvents are tweenTween-80. According to the preparation method, fresh herba houttuyniae, honeysuckle flowers and herba elsholtziaeelsholtzia subjected to clean washing, hot air drying, ultraviolet light disinfection and powder grinding in advance are respectively extracted by a supercritical extractor; then, 1 part of fresh herba houttuyniae supercritical CO2 extracts, 1 part of honeysuckle flowers supercritical CO2 extracts and 1 part of herba elsholtziaeelsholtzia supercritical CO2 extracts are taken and are mixed; the tweenTween-80 is added for hydrotropyassisting dissolving;injection water or pure water is usedare added for ultrafiltration membrane filtering; filter liquid is filled charged to obtain a finished product. The oral liquid is used as heath care food; traditional Chinese medicine and western medicine is are matched for achieve the functions of clearing away heat, purging intense heat, promoting diuresis, dispelling dampness, diminishing inflammation and eliminating toxin on childrenpediatric upper respiratory infection; the oral liquid is also effective for adult patients. The oral liquid provided by the invention is easy to for infants to take; the symptoms and pain of patients can be reducedalleviated; the oral liquid can be applied to adjuvantauxiliary treatment of childrenpediatric upper respiratory infection.

The invention relates to a pharmaceutical composition for treating acute upper respiratory infection. The pharmaceutical composition is a medicament which is prepared from the following raw material medicines: Semen sesami nigrum, manchurian lilac barks, albizia flower, mung beans, humifuse euphorbia herb, Semen Cuscutae, scorpio, terminalia chebula retz, lophatherum gracile, rhizoma bolbostemmae, Semen Euryales, radix tinosporae, lotus stamen, Chinese violet, hawthorn, Chinese azalea flowers, longan aril, piemarker, stalactite, pokeberry root, Sedum sarmentosum, zaocys dhumnade, szechwan Chinaberry fruit, cockscomb, concha haliotidis, cortex dictamni, fructus polygoni orientalis, radix psammosilenes, potentilla chinensis, lignum pini nodi tumorisati, vine of multiflower knotweed, ovateleaf holly barks, teasel roots, roses, lindley eupatorium, pterocephalus hookeri heck, folium eriobotryae, Chinese Starjasmine Stems, flos daturae, madder, Morinda officinalis, exocarpium benincasae, Platycodon grandiflorum, spina gleditsiae, ramulus mori, Folium Turpiniae, radix ranunculi ternate, elsholtzia, dayflowers and kamuning. The pharmaceutical composition provided by the invention is reasonable in formula and exact in curative effect, and can be used for effectively treating acute upper respiratory infection.

The invention relates to a Chinese medicinal preparation for treating common cold in children. The Chinese medicinal preparation is prepared by processing sinkiang arnebia root skin, indigowoad leaf, weeping forsythia, bupleurum, root of red-rooted salvia, arisaema cum bile, cicada slough, perilla leaf, ussuriensis fritillary bulb, tabasheer and mint; and the Chinese medicinal preparation has themain effects of clearing heat and detoxicating, facilitating lung and relieving exterior, and preventing phlegm from forming and stopping coughing and obvious effects on the symptoms such as wind-heat in children, and fever, cough, nasal obstruction, red pharynx, and abundance of phlegm which are caused by internal depression transforming into fire, or cough and asthma, red tongue, yellow or greasy tongue coating, rapid pulse and the like, and the obvious effect of treating acute upper respiratory infection and acute bronchitis of children, can be taken safely, and has no adverse and toxic effect.

The invention discloses patchouli oil soft capsules for treating acute upper respiratory infection and a treatment method thereof. Patchouli is an important Lingnan genuine medicinal material; and patchouli oil is a volatile component of the patchouli and is widely applied as medicinal extract. The patchouli oil has wide pharmacologic effects of resisting to bacteria, resisting to viruses, resisting to inflammation, relieving cough and reducing sputum, alleviating pain, resisting to plasmodia, regulating a gastrointestinal motion function, carrying out immunoregulation and the like. Accordingto the invention, the patchouli oil is used as a pharmaceutical effect ingredient; the patchouli oil is prepared into a soft capsule dosage form; an electronic heater is used as a drug delivery tool;the soft capsules are broken by utilizing a mechanical structure of the heater so as to slowly release volatile oil contained in the soft capsules; in an electrical heating mode, the volatile oil is vaporized; the vaporized volatile oil is inhaled into the respiratory tract through a mouth and a nose; and pharmaceutical effect molecules can directly reach lesion positions of a nasal cavity, a pharyngeal part, a throat and the like and rapidly take effects. The treatment method is used as a respiratory system disease targeted drug delivery approach, has obvious quick-acting and positioning effects, adopts local application, is rapid in pharmaceutical effect and small in dosage, and has an obvious curative effect of treating acute upper respiratory infection.

The invention relates to a traditional Chinese medicinal preparation for treating infant respiratory tract infection and a preparation method thereof. The traditional Chinese medicinal preparation is characterized by being prepared from 175 to 525g of radix scutellariaes, 350 to 1,050g of lindley eupatorium herb, 175 to 525g of honeysuckle flower, 175 to 525g of herba commelinae, 640g of dextrin, 8g of steviosin and 3g of citric acid, which are prepared into 1,000g of particles. Optimally, the traditional Chinese medicinal preparation is prepared from 350g of the radix scutellariaes, 700g of the lindley eupatorium herb, 350g of the honeysuckle flower, 350g of the herba commelinae, 640g of the dextrin, 8g of the steviosin, 3g of the citric acid, which are prepared into 1,000g of particles. The traditional Chinese medicinal preparation has the effects of clearing away heat and toxic materials and relieving a cough and sore throat, is mainly applied to infantile acute upper respiratory infection syndrome / pattern of wind-cold in having the symptoms of fever, micro serious attack by wind, throat irritation or swelling, cough and floating pulse, and is convenient to take.

The invention relates to a pharmaceutical composition for treating acute upper respiratory tract infection and a preparation method thereof. The composition comprises the following drugs: honeysuckles, wild chrysanthemum, houttuynia cordata, bupleurum, menthol, borneol and eucalyptus oil. The pharmaceutical composition provided by the invention has the effects of solving the symptoms, benefiting the throat, dispelling wind and reducing heat by cooperative use of the drugs; the symptoms and roots can be treated; tonification and purgation are in combination, and the curative effect is definite.The pharmaceutical composition is applied to the acute upper respiratory tract infection, swollen sore throat and bronchial asthma and has a significantcurative effect on chronic bronchitis, acute and chronic bronchial asthma and the like.

The invention belongs to the technical field of medicines, and particularly relates to a traditional Chinese medicine composition for treating the acute upper respiratory infection, as well as a preparation method and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from sweet wormwood, baical skullcap roots, folium isatidis, bambusae caulis im taeniam, green fructus forsythiae, rhizome pinelliae preparata, green tangerine peels and poria cocos. The preparation method comprises the following steps: aqueous extraction of the raw materials, alcohol precipitation, concentration and drying, so as to obtain extractum. The composition is used for preparing pharmaceutical preparations for treating the acute upper respiratory infection.

The invention belongs to the technical field of medicines, and particularly relates to a traditional Chinese medicine composition for treating the acute upper respiratory infection, as well as a preparation method and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from sweet wormwood, baical skullcap roots, folium isatidis, bambusae caulis im taeniam, green fructus forsythiae, rhizome pinelliae preparata, green tangerine peels and poria cocos. The preparation method comprises the following steps: aqueous extraction of the raw materials, alcohol precipitation, concentration and drying, so as to obtain extractum. The composition is used for preparing pharmaceutical preparations for treating the acute upper respiratory infection.

The invention belongs to the field of traditional Chinese medicines and discloses a silkworm-cultured cordyceps militaris composition for preventing or treating respiratory disease and application of the silkworm-cultured cordyceps militaris composition. The silkworm-cultured cordyceps militaris composition for preventing or treating respiratory disease is mainly prepared from the following components in parts by weight: 30-70 parts of silkworm-cultured cordyceps militaris, 10-50 parts of cordyceps militaris, and 0.1-10 parts of arginine. A Chinese patent medicine prepared from the composition for preventing and treating the respiratory disease has excellent 5-lipoxygenase inhibitory activity, airway inhibitory activity, airway inflammation inhibitory effect, ear swelling antiphlogistic effect, and cough-relieving and phlegm-eliminating activities, and can be used for effectively preventing or treating respiratory organ diseases such as asthma, chronic obstructive pulmonary disease, acute and chronic bronchitis, anaphylactic rhinitis, cough, excessive phlegm, acute lower respiratory infection (bronchitis and capillary bronchitis), pharyngitis, amygdalitis, laryngitis and acute upper respiratory infection.

The invention relates to a traditional Chinese medicinal preparation for treating infantile pneumonia and a preparation method of the traditional Chinese medicinal preparation. The traditional Chinese medicinal preparation is prepared into a pharmaceutically acceptable preparation by decocting, filtering, condensing, mixing, sieving, drying and implementing other treatment on the following crude medicines in parts by weight: 175-250 parts of ephedra, 175-250 parts of scutellaria baicalensis, 175-250 parts of fructus perillae, 250-350 parts of liquorice, 250-350 parts of root bark of white mulberry, 250-370 parts of semen armeniacae amarae, 450-550 parts of cortex lycii radicis, 750-850 parts of gypsum and 200-270 parts of trichosanthes kirilowii maxim. The preparation is a pure traditional Chinese medicinal preparation, which is concrete in curative effect and low in toxic and side effect; the preparation, on treating common and frequently-occurring diseases in children such as acute upper respiratory infection, trachitis, pneumonia and the like, treats both symptoms and root causes, and can help patients rapidly recover. Meanwhile, the preparation, after being prepared into granules, facilitates patients to carry and take, and is good in taste, controllable in quality and good in safety.

The invention belongs to the field of traditional Chinese medicines and discloses a silkworm-cultured cordyceps militaris composition for preventing or treating respiratory disease and application of the silkworm-cultured cordyceps militaris composition. The silkworm-cultured cordyceps militaris composition for preventing or treating respiratory disease is mainly prepared from the following components in parts by weight: 30-70 parts of silkworm-cultured cordyceps militaris, 10-50 parts of cordyceps militaris, and 0.1-10 parts of arginine. A Chinese patent medicine prepared from the composition for preventing and treating the respiratory disease has excellent 5-lipoxygenase inhibitory activity, airway inhibitory activity, airway inflammation inhibitory effect, ear swelling antiphlogistic effect, and cough-relieving and phlegm-eliminating activities, and can be used for effectively preventing or treating respiratory organ diseases such as asthma, chronic obstructive pulmonary disease, acute and chronic bronchitis, anaphylactic rhinitis, cough, excessive phlegm, acute lower respiratory infection (bronchitis and capillary bronchitis), pharyngitis, amygdalitis, laryngitis and acute upper respiratory infection.

The invention discloses a traditional Chinese medicine preparation as well as a preparation method and application thereof. The traditional Chinese medicine preparation is prepared from the following raw materials: swamp mahogany, mercury flower, radix trichosanthis, folium isatidis, selaginella doederleinii hieron, dendrobe, radix glehniae, liquorice, a scutellaria baicalensis extract and calculus bovis factitius. The traditional Chinese medicine preparation disclosed by the invention has the effects of clearing away heat and toxic materials, purging intense heat and drying dampness, dispelling wind and heat, and relieving swelling and sore throat, and can be used for treating wind-heat syndromes such as wind-heat type common cold, warm disease and high fever, swollen sore throat, lung heat and dry cough, carbuncle swelling and sore toxin, pneumonia, acute tonsillitis, sphagitis, conjunctivitis, gingivitis, acute upper respiratory infection and the like.

The invention discloses a traditional Chinese medicinal preparation for treating acute upper respiratory infection in pediatrics. The acute upper respiratory infection in pediatrics is mainly caught by wind, cold, heat, dampness, dry and internal fire, and is caused by pathogen in lung, and can be treated by clearing heat, removing toxicity, facilitating lung to relieve exterior syndrome, eliminating phlegm, stopping cough, relieving convulsion and tranquilizing. According to the traditional Chinese medicinal preparation, traditional Chinese medicinal materials including goat horn, whorledleaf solomonseal rhizome, asarum insigne diels, white mulberry root-bark, bunge giantfennel root, ivy tree bark, spiral shell, cleisostoma scolopendrifolium, sedum lineare, siberian alder bark, leafy parnassia, gigantism rhodobryum herb and tung tree root are selected and decocted into decoction. Clinical tests prove that the total effective rate of the traditional Chinese medicinal preparation is 97.1 percent, and is remarkably superior to that of a control group.

The invention discloses a traditional Chinese medicine for treating acute upper respiratory infection. The traditional Chinese medicine is prepared from the following medicinal materials: folium mori, chrysanthemum, burdock, fructus forsythiae, platycodon grandiflorum, rhizoma phragmitis, stiff silkworms, bamboo leaf, licorice roots northwest origin, fermented soya beans, mint and fistular onion stalk. A preparation method of the traditional Chinese medicine comprises the following steps: adding 700ml of water into a first dose of the medicinal materials and decocting to 200ml, adding 500ml of water into a second dose of the medicinal materials and decocting to 200ml, and administrating twice a day, wherein the medicine is taken on an empty stomach in the morning and evening.

The invention relates to a traditional Chinese medicine preparation for treating acute upper respiratory infection. The traditional Chinese medicine preparation is prepared by the following traditional Chinese medicine raw materials in parts by weight: 10-30 parts of mentha haplocalyx, 10-30 parts of indigo plant, 10-40 parts of purple perilla, 10-50 parts of gypsum, 10-35 parts of stinkweed, 10-40 parts of rhizoma phragmitis, 10-30 parts of radix paeoniae alba, 10-40 parts of radix scrophulariae, 10-20 parts of indian strawberry, 10-30 parts of dried tangerine peel and 10-50 parts of semen trichosanthis. The traditional Chinese medicine preparation has the compatibility of medicines and the effects of cooling and dispersing exterior evil and clearing away heat and toxic materials, is quick in effect of treating the acute upper respiratory infection and good in curative effect and does not have any side effects.